Intravenous Ascorbic Acid for the Prevention of Postreperfusion Syndrome in Orthotopic Liver Transplantation: Protocol for a Randomized Controlled Trial

MLA

Luis Gajate, et al. “Intravenous Ascorbic Acid for the Prevention of Postreperfusion Syndrome in Orthotopic Liver Transplantation: Protocol for a Randomized Controlled Trial.” JMIR Research Protocols, vol. 12, Dec. 2023, p. e50091. EBSCOhost, https://doi.org/10.2196/50091.

APA

Luis Gajate, Inés de la Hoz, Mercedes Espiño, Maria del Carmen Martin Gonzalez, Cristina Fernandez Martin, Ascensión Martín-Grande, Diego Parise Roux, Oscar Pastor, Judith Villahoz, Miguel Ángel Rodriguez-Gandía, & Javier Nuño Vazquez. (2023). Intravenous Ascorbic Acid for the Prevention of Postreperfusion Syndrome in Orthotopic Liver Transplantation: Protocol for a Randomized Controlled Trial. JMIR Research Protocols, 12, e50091. https://doi.org/10.2196/50091

Chicago

Luis Gajate, Inés de la Hoz, Mercedes Espiño, Maria del Carmen Martin Gonzalez, Cristina Fernandez Martin, Ascensión Martín-Grande, Diego Parise Roux, et al. 2023. “Intravenous Ascorbic Acid for the Prevention of Postreperfusion Syndrome in Orthotopic Liver Transplantation: Protocol for a Randomized Controlled Trial.” JMIR Research Protocols 12 (December): e50091. doi:10.2196/50091.